Gene expression of early hypertrophic scar tissue screened by means of cDNA microarrays

Journal of Trauma - Injury, Infection and Critical Care

Volumn 57, Issue 6, 2004, Pages 1276-1286

  Wu, Jun ^a   Ma, Bing ^a   Yi, Shaoxuan ^a   Wang, Zhenxiang ^a   He, Weifeng ^a   Luo, Gaoxing ^a   Chen, Xiwei ^a   Wang, Xihua ^a   Chen, Alex ^b   Barisoni, Dino ^c  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c Verona Major Hospital   (Italy)

Author keywords

cDNA microarray; Gene; Hypertrophic scar

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; COMPLEMENTARY DNA; CYTOKINE; DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; INTERFERON; MESSENGER RNA; OSTEONECTIN; PROFILIN; TRANSFORMING GROWTH FACTOR BETA; TROPOMYOSIN; VIMENTIN;

ADULT; APOPTOSIS; ARTICLE; BURN; CLINICAL ARTICLE; COLLAGEN METABOLISM; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOSKELETON; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; HYPERTROPHIC SCAR; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; IN SITU HYBRIDIZATION; MALE; METABOLISM; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTO ONCOGENE; SCAR FORMATION;

ACTINS; ADULT; BURNS; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CICATRIX, HYPERTROPHIC; CYTOSKELETAL PROTEINS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; MALE; MUSCLE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 19944428538     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TA.0000108997.49513.DC     Document Type: Article

References (23)

1. Niessen FB, Spauwen PH, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg. 1999;104:1435-1458.
2. Yang GP, Ross DT, Kuang WW, et al. Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes. Nucleic Acids Res. 1999;27:1517-1123.
3. Schena M, Shalon D, Heller R, et al. Parallel human genome analysis microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci USA. 1996;93:10614-10619.
4. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
5. Shalon D, Smith SJ, Brown PO. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res. 1996;6:639-645.
6. Ehrlich HP, Desmouliere A, Diegelmanm RF, et al. Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol. 1994;145:105-106.
7. Macleod AR, Talbot K, Smillie LB, et al. Characterization of a cDNA defining a gene family encoding TM30pl, a human fibroblast tropomyosin. J Mol Biol. 1987;194:1-10.
8. Ferrari S, Battini R, Kaczmarek L, et al. Coding sequence and growth regulation of the human vimentin gene. Mol Cell Biol. 1986;6:3614-3620.
9. Honore B, Madsen PS, Andersen AH, et al. Cloning and expression of a novel human profiliri variant, profilin II. FEBS Lett. 1993;330:151-155.
10. Hunzelmann N, Hafner M, Anders S, Krieg T, Nischt R. BM40 (osteonectin, SPARC) is expressed both in the epidermal and in the dermal compartment of adult human skin. J Invest Dermatol. 1998;110:122-126.
11. Tai-Lan T, Larry S, et al. The molecular basis of keloid and hypertrophic scar formation. Mol Med Today. 1998;4:19-23.
12. Kai Z, Warren G, Leslie C, Jorge R, Sem P. Increased types I and III collagen and transforming growth factor-β1 mRNA and protein in hypertrophic burn scar. J Invest Dermatol. 1995;104:750-754.
13. Nedelec B, Ghahary A, Scott PG, Tredget EE. Control of wound contraction. Hand Clin. 2000;16:289-302.
14. Wang R, Ghahary A, Shen Q, Scott PG, Roy K, Tredget EE. Hypertrophic scar tissues and flbroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells. Wound Repair Regen. 2000;8:128-137.
15. Huang JS, Wang YH, Ling TY, Chuang SS, Johnson FE. Synthetic TGF-beta antagonist accelerates wound healing and reduces scarring. FASEB J. 2002;16:1269-1270.
16. Sproat JE, Dalcin A, Weitauer N, et al. Hypertrophic sternal scars: silicone gel sheet versus Kenalog injection treatment. Plast Reconstr Surg. 1992;90:988-992.
17. Raymond T, Jana KC, Avery BN, et al. Analysis of hypertrophic and normal scar gene expression with cDNA microarrays. J Burn Care Rehabil. 2000;21:541-550.
18. Linares HA. From wound to scar. Burns. 1996;22:339-352.
19. Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell. 2001;12:2730-2741.
20. Ronnov-Jessen L, Petersen OW. A function of filamentous alpha-smooth muscle actin: retardation of motility in fibroblasts. J Cell Biol. 1996;134:67-80.
21. Xue H, McCauley RL, Zhang W, Martini DK. Altered interleukin-6 expression in fibroblasts from hypertrophic burn scars. J Burn Care Rehabil. 2000;21:142-146.
22. Nedelec B, Shankowsky H, Scott PG, Ghahary A, Tredget EE. Myofibroblasts and apoptosis in human hypertrophic scars: the effect of interferon-alpha2b. Surgery. 2001;130:798-808.
23. Tredget EE, Shankowsky HA, Pannu R, et al. Transforming growth factor-beta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2b. Plast Reconstr Surg. 1998;102:1317-1328.